IL17A and AIDS: HIV/AIDS is a major risk factor for OPC and EPC, typically in patients with diminished CD4 T cell counts (<200 cells/mm3), whereas certain topical or systemic immunosuppressive agents also predispose to the infection such as corticosteroids [161], TNF-α inhibitors [162], and IL-17-targeted biologics (see below) [163].